Vaccitech (VACC) Short Interest Ratio & Short Volume

Short interest is the volume of Vaccitech shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 159,200 shares of VACC short. 0.45% of Vaccitech's shares are currently sold short. Learn More on Vaccitech's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.45% of Vaccitech's floating shares are currently sold short.

Vaccitech saw a decline in short interest in the month of October. As of October 15th, there was short interest totaling 159,200 shares, a decline of 71.4% from the previous total of 555,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Vaccitech currently has issued a total of 38,547,000 shares. Some of Vaccitech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vaccitech currently has a public float of 35,490,000 shares.

0.45% of Vaccitech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Vaccitech: Anixa Biosciences, Inc. (1.82%), IO Biotech, Inc. (0.15%), Cellectar Biosciences, Inc. (7.49%), Barinthus Biotherapeutics plc (0.04%), Oramed Pharmaceuticals Inc. (0.91%), Clearside Biomedical, Inc. (0.36%), Genelux Co. (10.22%), Abeona Therapeutics Inc (7.95%), ProPhase Labs, Inc. (1.95%), PMV Pharmaceuticals, Inc. (6.83%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.82 billion), T-Mobile US, Inc. ($3.69 billion), Occidental Petroleum Co. ($2.90 billion), TC Energy Co. ($2.74 billion), Tractor Supply ($2.28 billion), Rivian Automotive, Inc. ($1.92 billion), Moderna, Inc. ($1.77 billion), Celsius Holdings, Inc. ($1.72 billion), Coinbase Global, Inc. ($1.66 billion), and Royal Caribbean Cruises Ltd. ($1.65 billion). View all of the most shorted stocks.

Short selling VACC is an investing strategy that aims to generate trading profit from Vaccitech as its price is falling. VACC shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Vaccitech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VACC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VACC, twice per month. The most recent reporting period available is October, 15 2023.